Company Overview
Snapshot
Founded in January 2016, TMST operates with 1–10 employees. The company received a grant from MassChallenge Israel in November 2016, marking a key early milestone in its development.
Business overview
TMST is developing a non-invasive acoustic neuromodulation device designed to reduce spasticity through Targeted Modulated Sound Therapy. The company plans to introduce two acoustic wearables, a headset and a bone conduction device, both pre-installed with the TMST sound module. A companion app will offer professional support, guidance, and community features. TMST targets the healthcare market, including home care, hospitals, and clinics, operating within the Health Tech & Life Sciences sector with a focus on medical devices and mobile applications.
Log in to access full profile ›Company Intelligence Q&A
- What is TMST's core technology?
- TMST is developing a non-invasive acoustic neuromodulation device that uses Targeted Modulated Sound Therapy to decrease spasticity.
- What products does TMST plan to offer?
- TMST plans to develop and market two acoustic wearables: a headset and a bone conduction device, both pre-installed with the TMST sound module. An accompanying app will provide support and guidance.
- When was TMST founded?
- TMST was founded in January 2016.
- What markets does TMST target?
- TMST targets the healthcare market, including home care, hospitals, and clinics, focusing on healthcare providers and patients.